EDGAR Filing Documents for 0001104659-21-102512

Form 8-K - Current report:

SEC Accession No. 0001104659-21-102512

Filing Date

2021-08-10

Accepted

2021-08-10 06:55:46

Documents

Period of Report

2021-08-09

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FOMR 8-K	tm2124627d1_8k.htm	8-K	29280
2	EXHIBIT 4.1	tm2124627d1_ex4-1.htm	EX-4.1	107109
3	EXHIBIT 4.2	tm2124627d1_ex4-2.htm	EX-4.2	115394
4	EXHIBIT 5.1	tm2124627d1_ex5-1.htm	EX-5.1	9930
5	EXHIBIT 10.1	tm2124627d1_ex10-1.htm	EX-10.1	237021
6	EXHIBIT 10.2	tm2124627d1_ex10-2.htm	EX-10.2	54855
7	EXHIBIT 99.1	tm2124627d1_ex99-1.htm	EX-99.1	12536
8	GRAPHIC	tm2124627d1_ex10-2img001.jpg	GRAPHIC	26394
	Complete submission text file	0001104659-21-102512.txt		603877

Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452

Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043

EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)